Horizon Pharma Inc (NASDAQ:HZNP)
| 2.32 Data as of Jun 18 |  +0.07 / +3.11%Today’s Change | 1.97 Today|||52-Week Range 8.72 | -0.43% Year-to-Date |
Latest HZNP News | Press Releases
No recent news for Horizon Pharma Inc.
Today’s Trading
| Previous close | 2.25 |
| Today’s open | 2.25 |
| Day’s range | 2.24 - 2.32 |
| Volume | 175,551 |
| Average volume (3 months) | 391,987 |
| Market cap | $141.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | +82.01% |
| Earnings growth (this year) | +45.43% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +183.41% |
| P/E ratio | NM |
| Price/Sales | 4.61 |
| Price/Book | 1.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PTXPernix Therapeutics ... | +0.16 | +4.30% |
| AVEOAveo Pharmaceuticals... | -0.03 | -1.13% |
| OGXIOncoGenex Pharmaceut... | +0.05 | +0.50% |
| OMEROmeros Corp | +0.21 | +4.23% |
Data as of 4:00pm ET, 06/18/2013
Financials
| Next reporting date | August 9, 2013 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $19.6M |
| Annual profit (last year) | -$87.8M |
| Net profit margin | -447.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Timothy P. Walbert |
Senior VP-Clinical Development & Operations Amy Grahn |
Corporate headquarters Deerfield, Illinois |
Forecasts
